Novo Nordisk ADR · Buy at Week 5
NVO: Buy signal running, first management window approaching
Novo Nordisk ADR · Buy at Week 5
In Summary
Novo Nordisk ADR is at week 5 of a buy signal. The stop has already been moved to breakeven: position risk is zeroed out. The Health Care sector is in positive regime, but the weekly structure is weak bullish and MACD is deteriorating. The first management window arrives in 1 week: time to monitor, not to add.
Open BUY
·5th week from start
·US stocks
·T1
IQS Phase
35
ordinary
Signal Strength
70
high · wide & volatile
Sizing
FULL
Ranking
#68 / 161
US stocks in progress
Trade P&L %
-2.10%
from signal to today
restricted Platinum content